DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

4.12 -0.02 (-0.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $4.12 -0.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.13
Previous Close $4.14
Daily Range $4.10 - $4.17
52-Week Range $3.26 - $7.97
Market Cap $906.9M
P/E Ratio -17.25
Dividend (Yield) $0.00 (0.0%)
Volume 2,256,523
Average Daily Volume 4,016,995
Current FY EPS -$0.28





Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website:

News & Commentary Rss Feed

For This Obesity Drug, Europe Trumps the U.S.

Europe is key for Orexigen's Contrave. Shares jumped despite problems with the U.S. launch.

Belviq And Smoking Cessation - Clearing The Air

Arena's Smoking Cessation, Nash, Combination Belviq-Phentermine, Free Belviq Samples

Arena Pharmaceuticals: Belviq Sales Take A Modest Dip With Holiday

Arena Pharmaceuticals' (ARNA) Presents at Stifel Healthcare Conference (Transcript)

Janssen Is Working Its Way Toward Anti-Obesity

EnteroMedics May Enter The Obesity Space - What Does It Mean?

Belviq Weekly Sales Come In Flat

Belviq For Smoking Cessation - Sizzle Or Smolder?

Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue? - Tale of the Tape

Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue? - Tale of the Tape

See More ARNA News...

ARNA's Top Competitors

ARNA $4.12 (-0.48%)
Current stock: ARNA
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB